Register Now for the 7th Annual Digi-Tech Pharma & AI Conference: London, United Kingdom - May 28-29, 2024

DUBLIN, March 15, 2024 /PRNewswire/ -- The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering.

The 7th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry.

Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 7th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.

The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.

The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry's digital transformation.

It gives us a great pleasure in welcoming you to our whole new pharmaceutical technology conference 7th Annual Digi-Tech Pharma & AI 2024.

KEY HIGHLIGHTS

Reimagining Pharma by Integrating Science and Technology:

• Digital Technology trends in Pharma and Bio-Tech industry
• Adopting AI and Machine Learning to unlock the full potential of Pharma
• How pharma can integrate into digital health environment
• Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
• Patient Centred Drug Discovery

Digital Discovery and Clinical Trials:

• Applying AI to the design of lead compounds for new drugs
• Algorithms and Models for drug discovery
• AI and ML for Target Identification & Validation in Drug Discovery
• Advancing Drug Discovery through quantum computing
• Genomics & Drug Discovery
• Virtual and Hybrid Clinical Trials
• R&D Use Cases

Decoding the Value of Data Science, Big Data & Informatics:

• Implementation and relevance of FAIR data principles in Pharma R&D
• Harnessing Data Science for Drug Combination Discovery
• AI and Big Data: A powerful combination for future growth
• The use of AI to make sense of clinical data
• Use of big data for precision medicine
• Multi-omics & clinical data to unlock the power of complex datasets
• Integration and Visualization of translational Medicine Data
• Data & Healthcare Analytics

Real-World Data & Real-World Evidence:

• The Growing Importance of Real-World Data
• RWD for clinical research and drug development
• RWE and RWD to support regulatory decision making
• Real?World Data Science to advance Patient Care
• Managing real world data governance

Digital Health & Future Innovations:

• Healthcare & Medical Technology
• Adoption of IoT in Pharma
• Potential of Cloud Computing in Pharma
• Impact of Digital Health in Pharma
• Digital Health strategy and Patient centric Clinical Trials
• The convergence of Digital Therapeutics and Pharma in Digital Health
• How pharma-health collaboration works on innovating drug discovery & patient experience
• Blockchain and AI-based Platform

Who Should Attend:

This event is designed for senior-level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO's, Diagnostics, solution provider and government institutions.

Attendees include Chief Data Officer, VPs, GMs, Directors, Heads, and Managers of

• Drug Discovery
• Drug Delivery Innovation
• R&D IT
• Big Data Solutions
• AI/ Machine Learning
• Cognitive Computing
• Digital innovative strategic planning
• Regulatory and pharmacovigilance
• IT Strategy
• Real-World Data
• Real-World Evidence
• Data Management & Analytics
• Data Science
• Clinical trials and data management
• Translational informatics
• Data storage and analysis
• Enterprise Architecture
• Information Systems
• Contract outsourcing service providers
• Digital Health
• Genomics
• Healthcare IT
• Multi-channel Management

Speakers

Mark Duman
Managing Director/ Chief Patient Officer
MD Healthcare Consultants

Cem Asma
Team Agility Lead
Novartis

Paolo Avalle
Director
MSD

Konrad Dobschuetz
National Director
NHS Innovation Accelerator

Jakob E. Larsen
Target Discovery Engine Project Director
Novo Nordisk

Paul Agapow
Director
GSK

Cedric Berger
Head of Knowledge Extraction and Integration
Roche

Ian Pepper
Director Technology Innovation
Novartis

Julio Molineros
Associate Director
The Janssen Pharmaceutical companies of Johnson & Johnson

James Duboff
Strategic Partnerships Director
Genomics England

Abhishek Pandey
Group Lead - Pharma discovery
AbbVie

Ghaith Sankari
Head of Global Digital Health Data Science
Bayer

Helene Vioix
Director Global Evidence & Value Development Oncology
Merck KGaA

Mohamed Sharaf
EMEA Senior Medical Advisor- Immunology
Janssen Europe, Middle East & Africa

Jost Leemhuis
Safety Science Partner and Global Business Lead
Roche

Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk

Andy Cachaldora
General Manager Digital Service Northern Europe
GE Healthcare

Leslie Anne Fendt
Global Program Head, Remote Vision Monitoring (Digital Health)
Roche

Linus Kao
Senior Expert Decentralized Clinical Trial (DCT)
Novartis

Jonas Abdel-Khalik
Digital Health Lead Nordics
Takeda

Spencer Jones
Snr Digital Health Lead
Bristol Myers Squibb

Irena Brookes-Smith
Head of Healthcare Analytics
AstraZeneca

Daniyal Hussain
Executive Director, Technology Business Development
GSK

Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk

Marcos Camara
Digital Solutions Senior Manager
Astellas Pharma Europe

Jimmy Toulas
Real World and Commercial Data Director, EMEA & China
Pfizer

Paula Salme Sandrak
Product Strategist (dHealth & Health AI)
Bayer

Mohammad Hassan Khalid
Machine learning and Data science
AstraZeneca

For more information about this conference visit https://www.researchandmarkets.com/r/3yc8e4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets